APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olaparib API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Olaparib API Industry Growth and Trends Forecast to 2032

26 December 2025102 pages

Choose your research edition.

Industry ResearchOlaparib API Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Olaparib API Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Olaparib API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olaparib API Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Olaparib API Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Olaparib API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Olaparib API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Olaparib API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Olaparib API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Olaparib API include Novartis AG, Pfizer, Bayer AG, Transo-Pharm USA LLC, Sun Pharmaceutical Industrial, ScinoPham Taiwan, MSN Laboratories, Exelixis and DR. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Olaparib API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Olaparib API market size, estimates, and forecasts are presented in terms of sales volume (Kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Olaparib API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Olaparib API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Olaparib API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Olaparib API Market by Company

Novartis AG

Pfizer

Bayer AG

Transo-Pharm USA LLC

Sun Pharmaceutical Industrial

ScinoPham Taiwan

MSN Laboratories

Exelixis

DR. Reddy's Laboratories

AstraZeneca

ALP Pharm Beijing

Alembic Pharmaceuticals

Olaparib API Segment by Type

Ovarian Cancer

Prostate Cancer

Breast Cancer

Pancreatic Cancer

Olaparib API Segment by Application

Pharmaceuticals

Biomedical

Others

Olaparib API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olaparib API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olaparib API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olaparib API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Olaparib API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Olaparib API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Ovarian Cancer Table 2. Major Company of Prostate Cancer Table 3. Major Company of Breast Cancer Table 4. Major Company of Pancreatic Cancer Table 5. Global Olaparib API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Olaparib API Sales by Type (2021-2026) & (Kg) Table 7. Global Olaparib API Sales Market Share in Volume by Type (2021-2026) Table 8. Global Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 9. Global Olaparib API Sales Market Share in Value by Type (2021-2026) Table 10. Global Olaparib API Price by Type (2021-2026) & (US$/g) Table 11. Global Olaparib API Sales by Type (2027-2032) & (Kg) Table 12. Global Olaparib API Sales Market Share in Volume by Type (2027-2032) Table 13. Global Olaparib API Sales by Type (2027-2032) & (US$ Million) Table 14. Global Olaparib API Sales Market Share in Value by Type (2027-2032) Table 15. Global Olaparib API Price by Type (2027-2032) & (US$/g) Table 16. North America Olaparib API Sales by Type (2021-2026) & (Kg) Table 17. North America Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Olaparib API Sales by Type (2021-2026) & (Kg) Table 19. Europe Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Olaparib API Sales by Type (2021-2026) & (Kg) Table 21. Asia-Pacific Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Olaparib API Sales by Type (2021-2026) & (Kg) Table 23. Latin America Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Olaparib API Sales by Type (2021-2026) & (Kg) Table 25. Middle East and Africa Olaparib API Sales by Type (2021-2026) & (US$ Million) Table 26. Olaparib API Industry Trends Table 27. Olaparib API Industry Drivers Table 28. Olaparib API Industry Opportunities and Challenges Table 29. Olaparib API Industry Restraints Table 30. Global Olaparib API Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Olaparib API Revenue Market Share by Company (2021-2026) Table 32. Global Olaparib API Sales by Company (2021-2026) & (Kg) Table 33. Global Olaparib API Sales Share by Company (2021-2026) Table 34. Global Olaparib API Market Price by Company (2021-2026) & (US$/g) Table 35. Global Olaparib API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Olaparib API Major Company Production Sites and Headquarters Table 37. Global Olaparib API Company, Product Type & Application Table 38. Global Olaparib API Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Olaparib API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Olaparib API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Olaparib API Sales by Region (2021-2026) & (Kg) Table 43. Global Olaparib API Sales Market Share in Volume by Region (2021-2026) Table 44. Global Olaparib API Sales by Region (2021-2026) & (US$ Million) Table 45. Global Olaparib API Sales Market Share in Value by Region (2021-2026) Table 46. Global Olaparib API Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 47. Global Olaparib API Sales by Region (2027-2032) & (Kg) Table 48. Global Olaparib API Sales Market Share in Volume by Region (2027-2032) Table 49. Global Olaparib API Sales by Region (2027-2032) & (US$ Million) Table 50. Global Olaparib API Sales Market Share in Value by Region (2027-2032) Table 51. Global Olaparib API Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 52. Global Olaparib API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Olaparib API Sales by Application (2021-2026) & (Kg) Table 54. Global Olaparib API Sales Market Share in Volume by Application (2021-2026) Table 55. Global Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 56. Global Olaparib API Sales Market Share in Value by Application (2021-2026) Table 57. Global Olaparib API Price by Application (2021-2026) & (US$/g) Table 58. Global Olaparib API Sales by Application (2027-2032) & (Kg) Table 59. Global Olaparib API Sales Market Share in Volume by Application (2027-2032) Table 60. Global Olaparib API Sales by Application (2027-2032) & (US$ Million) Table 61. Global Olaparib API Sales Market Share in Value by Application (2027-2032) Table 62. Global Olaparib API Price by Application (2027-2032) & (US$/g) Table 63. North America Olaparib API Sales by Application (2021-2026) & (Kg) Table 64. North America Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Olaparib API Sales by Application (2021-2026) & (Kg) Table 66. Europe Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Olaparib API Sales by Application (2021-2026) & (Kg) Table 68. Asia-Pacific Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Olaparib API Sales by Application (2021-2026) & (Kg) Table 70. Latin America Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Olaparib API Sales by Application (2021-2026) & (Kg) Table 72. Middle East and Africa Olaparib API Sales by Application (2021-2026) & (US$ Million) Table 73. Novartis AG Company Information Table 74. Novartis AG Business Overview Table 75. Novartis AG Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 76. Novartis AG Olaparib API Product Portfolio Table 77. Novartis AG Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 81. Pfizer Olaparib API Product Portfolio Table 82. Pfizer Recent Development Table 83. Bayer AG Company Information Table 84. Bayer AG Business Overview Table 85. Bayer AG Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 86. Bayer AG Olaparib API Product Portfolio Table 87. Bayer AG Recent Development Table 88. Transo-Pharm USA LLC Company Information Table 89. Transo-Pharm USA LLC Business Overview Table 90. Transo-Pharm USA LLC Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 91. Transo-Pharm USA LLC Olaparib API Product Portfolio Table 92. Transo-Pharm USA LLC Recent Development Table 93. Sun Pharmaceutical Industrial Company Information Table 94. Sun Pharmaceutical Industrial Business Overview Table 95. Sun Pharmaceutical Industrial Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Industrial Olaparib API Product Portfolio Table 97. Sun Pharmaceutical Industrial Recent Development Table 98. ScinoPham Taiwan Company Information Table 99. ScinoPham Taiwan Business Overview Table 100. ScinoPham Taiwan Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 101. ScinoPham Taiwan Olaparib API Product Portfolio Table 102. ScinoPham Taiwan Recent Development Table 103. MSN Laboratories Company Information Table 104. MSN Laboratories Business Overview Table 105. MSN Laboratories Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 106. MSN Laboratories Olaparib API Product Portfolio Table 107. MSN Laboratories Recent Development Table 108. Exelixis Company Information Table 109. Exelixis Business Overview Table 110. Exelixis Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 111. Exelixis Olaparib API Product Portfolio Table 112. Exelixis Recent Development Table 113. DR. Reddy's Laboratories Company Information Table 114. DR. Reddy's Laboratories Business Overview Table 115. DR. Reddy's Laboratories Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 116. DR. Reddy's Laboratories Olaparib API Product Portfolio Table 117. DR. Reddy's Laboratories Recent Development Table 118. AstraZeneca Company Information Table 119. AstraZeneca Business Overview Table 120. AstraZeneca Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 121. AstraZeneca Olaparib API Product Portfolio Table 122. AstraZeneca Recent Development Table 123. ALP Pharm Beijing Company Information Table 124. ALP Pharm Beijing Business Overview Table 125. ALP Pharm Beijing Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 126. ALP Pharm Beijing Olaparib API Product Portfolio Table 127. ALP Pharm Beijing Recent Development Table 128. Alembic Pharmaceuticals Company Information Table 129. Alembic Pharmaceuticals Business Overview Table 130. Alembic Pharmaceuticals Olaparib API Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 131. Alembic Pharmaceuticals Olaparib API Product Portfolio Table 132. Alembic Pharmaceuticals Recent Development Table 133. North America Olaparib API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 134. North America Olaparib API Sales by Country (2021-2026) & (Kg) Table 135. North America Olaparib API Sales Market Share by Country (2021-2026) Table 136. North America Olaparib API Sales Forecast by Country (2027-2032) & (Kg) Table 137. North America Olaparib API Sales Market Share Forecast by Country (2027-2032) Table 138. North America Olaparib API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Olaparib API Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Olaparib API Market Share by Country (2021-2026) Table 141. North America Olaparib API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Olaparib API Market Share Forecast by Country (2027-2032) Table 143. Europe Olaparib API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 144. Europe Olaparib API Sales by Country (2021-2026) & (Kg) Table 145. Europe Olaparib API Sales Market Share by Country (2021-2026) Table 146. Europe Olaparib API Sales Forecast by Country (2027-2032) & (Kg) Table 147. Europe Olaparib API Sales Market Share Forecast by Country (2027-2032) Table 148. Europe Olaparib API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Olaparib API Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Olaparib API Market Share by Country (2021-2026) Table 151. Europe Olaparib API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Olaparib API Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Olaparib API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Olaparib API Sales by Country (2021-2026) & (Kg) Table 155. Asia-Pacific Olaparib API Sales Market Share by Country (2021-2026) Table 156. Asia-Pacific Olaparib API Sales Forecast by Country (2027-2032) & (Kg) Table 157. Asia-Pacific Olaparib API Sales Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Olaparib API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Olaparib API Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Olaparib API Market Share by Country (2021-2026) Table 161. Asia-Pacific Olaparib API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Olaparib API Market Share Forecast by Country (2027-2032) Table 163. Latin America Olaparib API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 164. Latin America Olaparib API Sales by Country (2021-2026) & (Kg) Table 165. Latin America Olaparib API Sales Market Share by Country (2021-2026) Table 166. Latin America Olaparib API Sales Forecast by Country (2027-2032) & (Kg) Table 167. Latin America Olaparib API Sales Market Share Forecast by Country (2027-2032) Table 168. Latin America Olaparib API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America Olaparib API Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America Olaparib API Market Share by Country (2021-2026) Table 171. Latin America Olaparib API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America Olaparib API Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Olaparib API Market Size Growth Rate (CAGR) by Country (Kg): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Olaparib API Sales by Country (2021-2026) & (Kg) Table 175. Middle East and Africa Olaparib API Sales Market Share by Country (2021-2026) Table 176. Middle East and Africa Olaparib API Sales Forecast by Country (2027-2032) & (Kg) Table 177. Middle East and Africa Olaparib API Sales Market Share Forecast by Country (2027-2032) Table 178. Middle East and Africa Olaparib API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Middle East and Africa Olaparib API Market Size by Country (2021-2026) & (US$ Million) Table 180. Middle East and Africa Olaparib API Market Share by Country (2021-2026) Table 181. Middle East and Africa Olaparib API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Middle East and Africa Olaparib API Market Share Forecast by Country (2027-2032) Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Olaparib API Distributors List Table 186. Olaparib API Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Olaparib API Image Figure 2. Global Olaparib API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olaparib API Market Size (2021-2032) & (US$ Million) Figure 4. Global Olaparib API Sales (2021-2032) & (Kg) Figure 5. Ovarian Cancer Image Figure 6. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 7. Prostate Cancer Image Figure 8. Global Prostate Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 9. Breast Cancer Image Figure 10. Global Breast Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 11. Pancreatic Cancer Image Figure 12. Global Pancreatic Cancer Sales YoY Growth (2021-2032) & (Kg) Figure 13. Global Olaparib API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Olaparib API Market Share by Type 2025 VS 2032 Figure 15. North America Olaparib API Sales Market Share in Volume by Type in 2025 Figure 16. North America Olaparib API Sales Market Share in Value by Type in 2025 Figure 17. Europe Olaparib API Sales Market Share in Volume by Type in 2025 Figure 18. Europe Olaparib API Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Olaparib API Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Olaparib API Sales Market Share in Value by Type in 2025 Figure 21. Latin America Olaparib API Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Olaparib API Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Olaparib API Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Olaparib API Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Olaparib API Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Pharmaceuticals Image Figure 28. Global Pharmaceuticals Sales YoY Growth (2021-2032) & (Kg) Figure 29. Biomedical Image Figure 30. Global Biomedical Sales YoY Growth (2021-2032) & (Kg) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (Kg) Figure 33. Global Olaparib API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Olaparib API Market Share by Application 2025 VS 2032 Figure 35. North America Olaparib API Sales Market Share in Volume by Application in 2025 Figure 36. North America Olaparib API Sales Market Share in Value by Application in 2025 Figure 37. Europe Olaparib API Sales Market Share in Volume by Application in 2025 Figure 38. Europe Olaparib API Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Olaparib API Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Olaparib API Sales Market Share in Value by Application in 2025 Figure 41. Latin America Olaparib API Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Olaparib API Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Olaparib API Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Olaparib API Sales Market Share in Value by Application in 2025 Figure 45. North America Olaparib API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 46. North America Olaparib API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Olaparib API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Olaparib API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Olaparib API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 50. Europe Olaparib API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Olaparib API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Olaparib API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Olaparib API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 54. Asia-Pacific Olaparib API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Olaparib API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Olaparib API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Olaparib API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 58. Latin America Olaparib API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Olaparib API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Olaparib API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Olaparib API Sales by Country: 2021 VS 2025 VS 2032 (Kg) Figure 62. Middle East and Africa Olaparib API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Olaparib API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Olaparib API Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Olaparib API Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Olaparib API Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Ovarian Cancer
  • Prostate Cancer
  • Breast Cancer
  • Pancreatic Cancer
Applications
  • Pharmaceuticals
  • Biomedical
  • Others
Companies covered
  • Novartis AG
  • Pfizer
  • Bayer AG
  • Transo-Pharm USA LLC
  • Sun Pharmaceutical Industrial
  • ScinoPham Taiwan
  • MSN Laboratories
  • Exelixis
  • DR. Reddy's Laboratories
  • AstraZeneca
  • ALP Pharm Beijing
  • Alembic Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Olaparib API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Olaparib API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Olaparib API Market by Type
  6. 1.3.1 Ovarian Cancer
  7. 1.3.2 Prostate Cancer
  8. 1.3.3 Breast Cancer
  9. 1.3.4 Pancreatic Cancer
  10. 1.4 Global Olaparib API Market Size by Type
  11. 1.4.1 Global Olaparib API Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Olaparib API Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Olaparib API Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Olaparib API Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Olaparib API Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Olaparib API Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Olaparib API Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Olaparib API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Olaparib API Industry Trends
  2. 2.2 Olaparib API Industry Drivers
  3. 2.3 Olaparib API Industry Opportunities and Challenges
  4. 2.4 Olaparib API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Olaparib API Revenue (2021-2026)
  2. 3.2 Global Top Players by Olaparib API Sales (2021-2026)
  3. 3.3 Global Top Players by Olaparib API Price (2021-2026)
  4. 3.4 Global Olaparib API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Olaparib API Major Company Production Sites & Headquarters
  6. 3.6 Global Olaparib API Company, Product Type & Application
  7. 3.7 Global Olaparib API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Olaparib API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Olaparib API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Olaparib API Tier 1, Tier 2, and Tier 3
4 Olaparib API Regional Status and Outlook
  1. 4.1 Global Olaparib API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Olaparib API Historic Market Size by Region
  3. 4.2.1 Global Olaparib API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Olaparib API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Olaparib API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Olaparib API Forecasted Market Size by Region
  7. 4.3.1 Global Olaparib API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Olaparib API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Olaparib API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Olaparib API by Application
  1. 5.1 Olaparib API Market by Application
  2. 5.1.1 Pharmaceuticals
  3. 5.1.2 Biomedical
  4. 5.1.3 Others
  5. 5.2 Global Olaparib API Market Size by Application
  6. 5.2.1 Global Olaparib API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Olaparib API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Olaparib API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Olaparib API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Olaparib API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Olaparib API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Olaparib API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Olaparib API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis AG
  2. 6.1.1 Novartis AG Company Information
  3. 6.1.2 Novartis AG Business Overview
  4. 6.1.3 Novartis AG Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis AG Olaparib API Product Portfolio
  6. 6.1.5 Novartis AG Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Olaparib API Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Bayer AG
  14. 6.3.1 Bayer AG Company Information
  15. 6.3.2 Bayer AG Business Overview
  16. 6.3.3 Bayer AG Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bayer AG Olaparib API Product Portfolio
  18. 6.3.5 Bayer AG Recent Developments
  19. 6.4 Transo-Pharm USA LLC
  20. 6.4.1 Transo-Pharm USA LLC Company Information
  21. 6.4.2 Transo-Pharm USA LLC Business Overview
  22. 6.4.3 Transo-Pharm USA LLC Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Transo-Pharm USA LLC Olaparib API Product Portfolio
  24. 6.4.5 Transo-Pharm USA LLC Recent Developments
  25. 6.5 Sun Pharmaceutical Industrial
  26. 6.5.1 Sun Pharmaceutical Industrial Company Information
  27. 6.5.2 Sun Pharmaceutical Industrial Business Overview
  28. 6.5.3 Sun Pharmaceutical Industrial Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sun Pharmaceutical Industrial Olaparib API Product Portfolio
  30. 6.5.5 Sun Pharmaceutical Industrial Recent Developments
  31. 6.6 ScinoPham Taiwan
  32. 6.6.1 ScinoPham Taiwan Company Information
  33. 6.6.2 ScinoPham Taiwan Business Overview
  34. 6.6.3 ScinoPham Taiwan Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ScinoPham Taiwan Olaparib API Product Portfolio
  36. 6.6.5 ScinoPham Taiwan Recent Developments
  37. 6.7 MSN Laboratories
  38. 6.7.1 MSN Laboratories Company Information
  39. 6.7.2 MSN Laboratories Business Overview
  40. 6.7.3 MSN Laboratories Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 MSN Laboratories Olaparib API Product Portfolio
  42. 6.7.5 MSN Laboratories Recent Developments
  43. 6.8 Exelixis
  44. 6.8.1 Exelixis Company Information
  45. 6.8.2 Exelixis Business Overview
  46. 6.8.3 Exelixis Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Exelixis Olaparib API Product Portfolio
  48. 6.8.5 Exelixis Recent Developments
  49. 6.9 DR. Reddy's Laboratories
  50. 6.9.1 DR. Reddy's Laboratories Company Information
  51. 6.9.2 DR. Reddy's Laboratories Business Overview
  52. 6.9.3 DR. Reddy's Laboratories Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 DR. Reddy's Laboratories Olaparib API Product Portfolio
  54. 6.9.5 DR. Reddy's Laboratories Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Olaparib API Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 ALP Pharm Beijing
  62. 6.11.1 ALP Pharm Beijing Company Information
  63. 6.11.2 ALP Pharm Beijing Business Overview
  64. 6.11.3 ALP Pharm Beijing Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 ALP Pharm Beijing Olaparib API Product Portfolio
  66. 6.11.5 ALP Pharm Beijing Recent Developments
  67. 6.12 Alembic Pharmaceuticals
  68. 6.12.1 Alembic Pharmaceuticals Company Information
  69. 6.12.2 Alembic Pharmaceuticals Business Overview
  70. 6.12.3 Alembic Pharmaceuticals Olaparib API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Alembic Pharmaceuticals Olaparib API Product Portfolio
  72. 6.12.5 Alembic Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Olaparib API Sales by Country
  2. 7.1.1 North America Olaparib API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Olaparib API Sales by Country (2021-2026)
  4. 7.1.3 North America Olaparib API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Olaparib API Market Size by Country
  6. 7.2.1 North America Olaparib API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Olaparib API Market Size by Country (2021-2026)
  8. 7.2.3 North America Olaparib API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Olaparib API Sales by Country
  2. 8.1.1 Europe Olaparib API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Olaparib API Sales by Country (2021-2026)
  4. 8.1.3 Europe Olaparib API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Olaparib API Market Size by Country
  6. 8.2.1 Europe Olaparib API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Olaparib API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Olaparib API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Olaparib API Sales by Country
  2. 9.1.1 Asia-Pacific Olaparib API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Olaparib API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Olaparib API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Olaparib API Market Size by Country
  6. 9.2.1 Asia-Pacific Olaparib API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Olaparib API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Olaparib API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Olaparib API Sales by Country
  2. 10.1.1 South America Olaparib API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Olaparib API Sales by Country (2021-2026)
  4. 10.1.3 South America Olaparib API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Olaparib API Market Size by Country
  6. 10.2.1 South America Olaparib API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Olaparib API Market Size by Country (2021-2026)
  8. 10.2.3 South America Olaparib API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Olaparib API Sales by Country
  2. 11.1.1 Middle East and Africa Olaparib API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Olaparib API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Olaparib API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Olaparib API Market Size by Country
  6. 11.2.1 Middle East and Africa Olaparib API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Olaparib API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Olaparib API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Olaparib API Value Chain Analysis
  2. 12.1.1 Olaparib API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Olaparib API Production Mode & Process
  7. 12.2 Olaparib API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Olaparib API Distributors
  10. 12.2.3 Olaparib API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst